Walleye Trading
ANTH

Walleye Trading’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History

Walleye Trading’s Portfolio ANTH Stock Details ANTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-5
Closed – – 5264
2017
Q1 		$0 Hold
5
– – ﹤0.01% 5403
2016
Q4 		$0 Buy
+5
New +$87 ﹤0.01% 5478
2015
Q4 		– Sell
-113
Closed -$5K – 5997
2015
Q3 		$5K Sell
113
-37
-25% -$2.58K ﹤0.01% 4642
2015
Q2 		$10K Buy
+150
New +$6.94K ﹤0.01% 4319

Other funds holding ANTH

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
ECM
Element Capital Management New York $1.05B AUM 5.05% 1-Year Est. Return

Walleye Trading's ANTH Position: Q2 2017 in Review

Walleye Trading sold out of Anthera Pharmaceuticals, Inc. (ANTH) in Q2 2017, closing a stake of 5 shares.

Walleye Trading first reported a position in ANTH in Q2 2015 and held it in 4 quarters. The position peaked at $10K in Q2 2015. 40 funds tracked by Wall St. Rank hold ANTH as of Q2 2017.

  • Walleye Trading reported no remaining Anthera Pharmaceuticals, Inc. position as of Q2 2017 after selling out during the quarter.
  • Walleye Trading sold 5 Anthera Pharmaceuticals, Inc. shares in Q2 2017.
  • Walleye Trading first reported a position in Anthera Pharmaceuticals, Inc. in Q2 2015 and held it in 4 quarters.
  • Walleye Trading's Anthera Pharmaceuticals, Inc. position peaked at $10K in Q2 2015.
  • 40 funds tracked by Wall St. Rank held Anthera Pharmaceuticals, Inc. as of Q2 2017.

Based on Walleye Trading's 13F filing for Q2 2017, filed 14 Aug 2017.